International Psoriasis Council

Advancing Knowledge. Improving Care.

Advancing Knowledge. Improving Care.

Infectious Diseases

As a global organization dedicated to improving the care of people with psoriasis, the International Psoriasis Council (IPC) recognizes the importance of addressing the complex relationship between infectious diseases and psoriasis. We strive to provide a comprehensive resource for dermatologists and patients by gathering and sharing the latest information on infectious diseases and psoriasis from around the world. If you have a relevant resource to contribute, please submit it to the IPC for consideration.   

COVID-19 & Psoriasis Resources

Resources from IPC and trusted sources to assist people with psoriasis in navigating the COVID-19 pandemic.

Monkeypox & Psoriasis Resources

Available resources to help individuals with psoriasis better understand the risks associated with monkeypox.

COVID-19 & Psoriasis Resources

The COVID-19 pandemic has raised concerns for individuals with psoriasis, who may question how the virus could affect them. To address these concerns, IPC has compiled a range of resources from trusted sources to assist those with psoriasis in navigating this challenging time. These resources provide information on the latest COVID-19 updates, advice on managing psoriasis during the pandemic, and guidance on mental health and well-being.

IPC Resources

PUBLICATIONS AND RESEARCH

Additional Resources

Below are resources from other organizations that examine the relationship between COVID-19 and psoriasis.

PUBLICATIONS AND RESEARCH

The Risk of Respiratory Tract Infections and Symptoms in Psoriasis Patients Treated with IL-17-pathway Inhibiting Biologics: A Meta-estimate of Pivotal Trials Relevant to Decision-making During the COVID-19 Pandemic. Wan MT, Shin DB, Winthrop KL, Gelfand JM. J Am Acad Dermatol. 2020 Aug;83(2):677-679. doi: 10.1016/j.jaad.2020.05.035. Epub 2020 May 19. PMID: 32416207; PMCID: PMC7235584.

Additional Information

IPC Statement on COVID-19 & Psoriasis

Read the statement from IPC’s Board of Directors based on the current understanding of the impact of COVID-19 and psoriasis.

PsoProtect International Registry

PsoProtect is an international registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. The registry seeks to improve our understanding of how factors such as immunomodulator therapies and comorbidities impact outcomes to COVID-19 in psoriasis. This information will inform clinicians when assessing risk and treating COVID-19 in patients with psoriasis.

Monkeypox & Psoriasis Resources

Monkeypox is a rare viral disease that can be particularly concerning for individuals with psoriasis due to their weakened immune systems. These resources aim to help those with psoriasis better understand the risks associated with monkeypox, including information on symptoms, diagnosis, and treatment options. We encourage individuals with psoriasis to explore these resources and consult a healthcare professional for personalized guidance on managing their condition.

Additional Resources

Below are resources from other organizations that examine the relationship between monkeypox and psoriasis.

PUBLICATIONS AND RESEARCH

Atlas of MPOX Lesions: A Tool for Clinical Researchers. World Health Organization. Version 1.0. World Health Organization, 2023. Accessed April 28, 2023.